BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32528411)

  • 1. Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue.
    Peculis R; Mandrika I; Petrovska R; Dortane R; Megnis K; Nazarovs J; Balcere I; Stukens J; Konrade I; Pirags V; Klovins J; Rovite V
    Front Endocrinol (Lausanne); 2020; 11():313. PubMed ID: 32528411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot genome-scale profiling of DNA methylation in sporadic pituitary macroadenomas: association with tumor invasion and histopathological subtype.
    Ling C; Pease M; Shi L; Punj V; Shiroishi MS; Commins D; Weisenberger DJ; Wang K; Zada G
    PLoS One; 2014; 9(4):e96178. PubMed ID: 24781529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
    Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
    Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary tumors contain a side population with tumor stem cell-associated characteristics.
    Mertens F; Gremeaux L; Chen J; Fu Q; Willems C; Roose H; Govaere O; Roskams T; Cristina C; Becú-Villalobos D; Jorissen M; Poorten VV; Bex M; van Loon J; Vankelecom H
    Endocr Relat Cancer; 2015 Aug; 22(4):481-504. PubMed ID: 25921430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome sequencing studies of nonfunctioning pituitary adenomas.
    Newey PJ; Nesbit MA; Rimmer AJ; Head RA; Gorvin CM; Attar M; Gregory L; Wass JA; Buck D; Karavitaki N; Grossman AB; McVean G; Ansorge O; Thakker RV
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E796-800. PubMed ID: 23450047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HEREDITARY PITUITARY TUMOR SYNDROMES: GENETIC AND CLINICAL ASPECTS.
    García-Guzmán B; Portocarrero-Ortiz L; Dorantes-Argandar AA; Mercado M
    Rev Invest Clin; 2020; 72(1):8-18. PubMed ID: 32132734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas.
    Zhou W; Zhang C; Zhang D; Peng J; Ma S; Wang X; Guan X; Li P; Li D; Jia G; Jia W
    J Neurooncol; 2020 Sep; 149(3):473-487. PubMed ID: 33034841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: recurrent pituitary adenoma has increased load of somatic variants.
    Peculis R; Balcere I; Radovica-Spalvina I; Konrade I; Caune O; Megnis K; Rovite V; Stukens J; Nazarovs J; Breiksa A; Kiecis A; Silamikelis I; Pirags V; Klovins J
    BMC Endocr Disord; 2020 Jan; 20(1):17. PubMed ID: 31996211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs and Target Genes in Pituitary Adenomas.
    Feng Y; Mao ZG; Wang X; Du Q; Jian M; Zhu D; Xiao Z; Wang HJ; Zhu YH
    Horm Metab Res; 2018 Mar; 50(3):179-192. PubMed ID: 29351706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of stem cell niche during experimental pituitary tumor development.
    Guido CB; Sosa LDV; Perez PA; Zlocoswki N; Velazquez FN; Gutierrez S; Petiti JP; Mukdsi JH; Torres AI
    J Neuroendocrinol; 2021 Dec; 33(12):e13051. PubMed ID: 34708474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing identifies novel mitochondrial variants in pituitary adenomas.
    Németh K; Darvasi O; Likó I; Szücs N; Czirják S; Reiniger L; Szabó B; Kurucz PA; Krokker L; Igaz P; Patócs A; Butz H
    J Endocrinol Invest; 2019 Aug; 42(8):931-940. PubMed ID: 30684245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
    Jaffrain-Rea ML; Angelini M; Gargano D; Tichomirowa MA; Daly AF; Vanbellinghen JF; D'Innocenzo E; Barlier A; Giangaspero F; Esposito V; Ventura L; Arcella A; Theodoropoulou M; Naves LA; Fajardo C; Zacharieva S; Rohmer V; Brue T; Gulino A; Cantore G; Alesse E; Beckers A
    Endocr Relat Cancer; 2009 Sep; 16(3):1029-43. PubMed ID: 19556287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
    Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
    J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational analysis identifies invasion-associated genes in pituitary adenomas.
    Cao C; Wang W; Ma C; Jiang P
    Mol Med Rep; 2015 Aug; 12(2):1977-82. PubMed ID: 25824863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitors of metalloproteinase-expressing cells in human anterior pituitary and pituitary adenoma.
    Tofrizal A; Fujiwara K; Azuma M; Kikuchi M; Jindatip D; Yashiro T; Yamada S
    Med Mol Morphol; 2017 Sep; 50(3):145-154. PubMed ID: 28353090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior.
    Vicchio TM; Aliquò F; Ruggeri RM; Ragonese M; Giuffrida G; Cotta OR; Spagnolo F; Torre ML; Alibrandi A; Asmundo A; Angileri FF; Esposito F; Polito F; Oteri R; Aguennouz MH; Cannavò S; Ferraù F
    J Endocrinol Invest; 2020 Jul; 43(7):947-958. PubMed ID: 31939196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into pituitary tumorigenesis: from Sanger sequencing to next-generation sequencing and beyond.
    Shen AJJ; King J; Scott H; Colman P; Yates CJ
    Expert Rev Endocrinol Metab; 2019 Nov; 14(6):399-418. PubMed ID: 31793361
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
    Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
    Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
    Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
    Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2 is highly expressed in pituitary adenomas and associated with proliferation.
    Schult D; Hölsken A; Siegel S; Buchfelder M; Fahlbusch R; Kreitschmann-Andermahr I; Buslei R
    Sci Rep; 2015 Nov; 5():16965. PubMed ID: 26593398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.